Adding to the pressure is that CVS Health has retained coverage of Zepbound's arch rival Wegovy (semaglutide), sold by Novo ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

The U.S. stock market continued to rebound from a period of volatility for the second straight week, with the S&P 500 closing ...

Here are Investing.com’s stocks of the week. Microsoft was one of many tech giants that reported earnings this week, with the company topping profit and revenue expectations. MSFT shares jumped more ...

NurExone Biologic Inc. ("NurExone" or the "Company"), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system injuries, is deepening its engagement with ...

NEW YORK CITY, NY / ACCESS Newswire / May 2, 2025 / In an era where healthcare is as much about timely access and ...

Ingredient Formula Targets Root Causes of Vision Decline—Blending Vitamins, Antioxidants, and Gut-Immune Support for Clearer ...